Detalhe da pesquisa
1.
Patient-derived xenograft mouse models to investigate tropism to the central nervous system and retina of primary and secondary central nervous system lymphoma.
Neuropathol Appl Neurobiol
; 49(2): e12899, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36879456
2.
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415).
BMC Cancer
; 23(1): 561, 2023 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37337155
3.
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial.
BMC Cancer
; 23(1): 767, 2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596517
4.
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma.
BMC Cancer
; 22(1): 971, 2022 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36088292
5.
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice.
Br J Haematol
; 189(5): 879-887, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31997308
6.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Lancet
; 393(10184): 1948-1957, 2019 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30982686
7.
Novel agents for primary central nervous system lymphoma: evidence and perspectives.
Blood
; 132(7): 681-688, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29986908
8.
Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma.
Blood
; 132(26): 2744-2753, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30249786
9.
Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients.
BMC Cancer
; 19(1): 287, 2019 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30925912
10.
Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis.
Hematol Oncol
; 37(5): 548-557, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31418878
11.
CNS relapse in DLBCL: a calculable risk?
Blood
; 137(8): 1011-1012, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33630050
12.
The role of autologous stem cell transplantation in primary central nervous system lymphoma.
Blood
; 127(13): 1642-9, 2016 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26834241
13.
Targetable genetic features of primary testicular and primary central nervous system lymphomas.
Blood
; 127(7): 869-81, 2016 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26702065
14.
International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma.
Haematologica
; 108(3): 882-888, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36300776
15.
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients.
BMC Cancer
; 17(1): 137, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28202004
16.
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
Lancet Oncol
; 17(12): 1697-1708, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27776843
17.
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
BMC Cancer
; 16: 282, 2016 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27098429
18.
Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer.
Br J Cancer
; 113(6): 872-7, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26335608
19.
Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single-centre analysis.
Br J Haematol
; 190(2): e110-e114, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452526
20.
CNS border posts against rituximab?
Lancet Oncol
; 20(2): 169-170, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630773